Assignee
N GENE RES LAB INC
US·12 granted patents·5 pending applications·118 citations·filing 1998–2015
Top patents by PatentIndex Score
17 records- 0193US6838469B2Pharmaceutical composition that exhibits reduced side-effects comprising O-(3-piperidino-2-hydroxy-1-propyl)nicotinic acid amidoxime and a pyrimidine derivative with known antitumor activityN GENE RES LAB INC·Filed 2002·Granted Jan 4, 2005·56 cites·12 claims
- 0278US6656955B2Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroximic acid derivativeN GENE RES LAB INC·Filed 2002·Granted Dec 2, 2003·10 cites·12 claims
- 0376US6720337B2Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroxlmic acid derivativeN GENE RES LAB INC·Filed 2002·Granted Apr 13, 2004·8 cites·6 claims
- 0473US6884424B2Method for treating the pathological lesions of the skin that develop by ultraviolet radiation of the sunlightN GENE RES LAB INC·Filed 2001·Granted Apr 26, 2005·8 cites·7 claims
- 0571US7151175B2Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the sameN GENE RES LAB INC·Filed 2005·Granted Dec 19, 2006·1 cites·4 claims
- 0669US7763601B2Prevention and treatment of obesityN GENE RES LAB INC·Filed 2007·Granted Jul 27, 2010·2 cites·3 claims
- 0761US8048873B2Synergistic pharmaceutical combination for the prevention or treatment of diabetesN GENE RES LAB INC·Filed 2009·Granted Nov 1, 2011·0 cites·5 claims
- 0859US7767694B2Pharmaceutical composition having prokinetic effectN GENE RES LAB INC·Filed 2009·Granted Aug 3, 2010·0 cites·7 claims
- 0956US6440998B1Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroximic acid derivativeN GENE RES LAB INC·Filed 1998·Granted Aug 27, 2002·10 cites·10 claims
- 1055US2009281143A1Dose Reduction of a Cannabinoid CB1 Receptor Antagonist in the Treatment of Overweight or ObesityN GENE RES LAB INC·Filed 2008·Application pending·0 cites
- 1152US2008108602A1Prevention of obesity in antipsychotic, antidepressant and antiepileptic medicationN GENE RES LAB INC·Filed 2007·Application pending·0 cites
- 1250US6451851B1Pharmaceutical composition with antiviral activity containing an hydroxymic acid derivative and an antiviral agentN GENE RES LAB INC·Filed 1998·Granted Sep 17, 2002·14 cites·7 claims
- 1349US6500823B1Unsaturated hydroximic acid derivatives as per abstract inhibitorsN GENE RES LAB INC·Filed 1999·Granted Dec 31, 2002·9 cites·25 claims
- 1448US7635674B2Synergistic pharmaceutical combination for the prevention or treatment of diabetesN GENE RES LAB INC·Filed 2002·Granted Dec 22, 2009·0 cites·4 claims
- 1543US2010311719A1Prevention of Obesity in Antipsychotic, Antidepressant and Antiepileptic MedicationN GENE RES LAB INC·Filed 2010·Application pending·0 cites
- 1641US2015366852A1Prevention of Obesity in Antipsychotic, Antidepressant and Antiepileptic MedicationN GENE RES LAB INC·Filed 2015·Application pending·0 cites
- 1736US2007281972A1Pharmaceutical Composition Having Prokinetic EffectN GENE RES LAB INC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when N GENE RES LAB INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →